|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0014939,
umls-concept:C0034802,
umls-concept:C0034833,
umls-concept:C0034897,
umls-concept:C0039286,
umls-concept:C0086418,
umls-concept:C0205195,
umls-concept:C0242957,
umls-concept:C0392762,
umls-concept:C0439849,
umls-concept:C0449438,
umls-concept:C0597360,
umls-concept:C0878174
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2008-3-3
|
|
pubmed:abstractText |
To determine the relationship between quantitative estrogen-receptor (ER) and progesterone-receptor (PgR) expression and human epidermal growth factor 2 (HER-2) status with time to recurrence (TTR) in postmenopausal women with hormone receptor-positive primary breast cancer treated with anastrozole or tamoxifen as adjuvant therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:AllredCraigC,
pubmed-author:BishopHughH,
pubmed-author:BuzdarAmanA,
pubmed-author:CarderPaulineP,
pubmed-author:CussacAntonio LlombartAL,
pubmed-author:CuzickJackJ,
pubmed-author:DowsettMitchM,
pubmed-author:EllisIanI,
pubmed-author:ForbesJohnJ,
pubmed-author:HoughtonJoanJ,
pubmed-author:KnoxFionaF,
pubmed-author:KnoxJillJ,
pubmed-author:LarsimontDenisD,
pubmed-author:MallonElizabethE,
pubmed-author:QuinnEmmaE,
pubmed-author:SalterJanineJ,
pubmed-author:SasanoHironobuH,
pubmed-author:SpeirsValerieV,
pubmed-author:WaleChrisC,
pubmed-author:WilliamsNormanN
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1059-65
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:18227529-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18227529-Breast Neoplasms,
pubmed-meshheading:18227529-Chemotherapy, Adjuvant,
pubmed-meshheading:18227529-Double-Blind Method,
pubmed-meshheading:18227529-Female,
pubmed-meshheading:18227529-Humans,
pubmed-meshheading:18227529-Middle Aged,
pubmed-meshheading:18227529-Neoplasm Recurrence, Local,
pubmed-meshheading:18227529-Nitriles,
pubmed-meshheading:18227529-Postmenopause,
pubmed-meshheading:18227529-Prognosis,
pubmed-meshheading:18227529-Receptor, erbB-2,
pubmed-meshheading:18227529-Receptors, Estrogen,
pubmed-meshheading:18227529-Receptors, Progesterone,
pubmed-meshheading:18227529-Retrospective Studies,
pubmed-meshheading:18227529-Survival Rate,
pubmed-meshheading:18227529-Tamoxifen,
pubmed-meshheading:18227529-Time Factors,
pubmed-meshheading:18227529-Tissue Array Analysis,
pubmed-meshheading:18227529-Treatment Outcome,
pubmed-meshheading:18227529-Triazoles
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial.
|
|
pubmed:affiliation |
Academic Department of Biochemistry, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, United Kingdom. mitch.dowsett@icr.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
